💼 Ready to shape the future of particle accelerators? We’re looking for passionate minds to join us on this mission. From engineering to clinical support, you can help us bring cutting-edge technology to life. 🔎 Discover some of our hot jobs: - Automation engineer https://lnkd.in/e97S6MK8 - Technical Operations Manager https://lnkd.in/eTiaY_w7 - Sales Support Associate https://lnkd.in/eaxJ-RsX - Head of System https://lnkd.in/edi248ck - Fitter https://lnkd.in/eUftdJkK - Technical Product Manager https://lnkd.in/eyRgvXzd Join a company where science and innovation meets purpose. 🌟
About us
IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered to be the most advanced form of radiation therapy available today, industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,000 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.
- Website
-
http://www.iba-group.com
External link for IBA
- Industry
- Medical Equipment Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Louvain-la-Neuve
- Type
- Public Company
- Specialties
- Proton Therapy, RadioPharma Solutions, Dosimetry, and Industrial Solutions
Locations
Employees at IBA
Updates
-
This November, IBA stands with the Movember movement to raise awareness for men’s health, including cancer prevention and mental well-being. As a company active in the diagnosis and treatment of prostate and testicular cancers, this cause deeply resonates with our mission. 💙 Let’s change the face of men’s health. Learn more: https://eu.movember.com/
🧔 𝐌𝐨𝐯𝐞𝐦𝐛𝐞𝐫. 𝐂𝐡𝐚𝐧𝐠𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐚𝐜𝐞 𝐨𝐟 𝐌𝐞𝐧'𝐬 𝐇𝐞𝐚𝐥𝐭𝐡! November turns blue worldwide as we unite to support men's health, not only in the fight against prostate and testicular cancers, but also in promoting mental well-being. 💡Prostate cancer is the most diagnosed cancer with approximately 30% of cancers this year. It is also the second most deadly cancer for men. It is not just about the color, but the meaning behind. 𝐌𝐨 𝐘𝐨𝐮𝐫 𝐎𝐰𝐧 𝐖𝐚𝐲💙 #Movember #IBACommunity *Source: Prostate cancer statistics, 2025 - Kratzer - CA: A Cancer Journal for Clinicians - https://lnkd.in/epCjy3VV Roland de Wouters, Arthur Cougnet, Arnaud Leman, Jean-Christophe Haji, Erwan della Faille de Leverghem, Baptiste Vander Motten, Kevan Waiengnier, Thomas Canon, Marian Vaduva, Frederic Jodocy, Juan Carlos Maltez Romillo, Frederic Schils, Pierric Brison, Charles Luyckx, Robert Kwizera, Julien Caulier, Yves Claereboudt, Noémie Emmanuel, Bertrand Sadzot, Jason Cowan, Maxime Michaux, Bastien Yilmaz, Paul-Henri Euzennat, Pawel Jurkiewicz, Jean-Michel Geets
-
At IBA, we believe science is for everyone. 🔬 Last month, IBA opened its doors to 25 secondary school girls. They discovered careers in science and technology alongside our female engineers. 🧬Every talent can shape the science of tomorrow. Explore careers at IBA and connect with a vibrant community of talented women: https://lnkd.in/dZASwi2R. Thank you to WomInTech , a student association promoting gender diversity in science and engineering, for their participation.
-
-
📢 Press release IBA announces the acquisition of PhantomX GmbH to integrate Artificial Intelligence Quality Assurance into its dosimetry solutions and expand its portfolio in healthcare diagnostics and therapeutic systems. 🔗 Read the full press release here: https://lnkd.in/dXM7x3nM
-
-
🩷 With over 2.3 million new breast cancer cases diagnosed annually, education and access to innovative treatments like proton therapy are essential to improving patient outcomes. IBA Proton Therapy is proud to support the Proton Therapy Academy, which equips medical professionals with the knowledge to deliver cutting-edge care. 👉 As an healthcare professional, researcher, or student, explore the dedicated course on proton therapy for breast cancer: https://lnkd.in/eAuaBJFm
🌸🎗 Raising Awareness for Breast Cancer Breast cancer continues to be a major global health challenge, with over 2.3 million new cases diagnosed each year. This month serves as an important opportunity to highlight advancements in treatment and the role of education in improving patient outcomes. At the Proton Therapy Academy, our mission is to equip healthcare professionals with the expertise to deliver cutting-edge cancer care. Proton therapy offers a highly precise approach to breast cancer treatment, minimizing radiation exposure to critical organs such as the heart and lungs. 📣 If you’re a healthcare professional, researcher, or student seeking to expand your knowledge of proton therapy for breast cancer, explore our Proton Therapy Clinical Education course: https://lnkd.in/eAuaBJFm Let’s advance education and collaboration to shape the future of breast cancer care. #ProtonTherapyAcademy #ClinicalTraining #MedicalEducation #Oncology #ProtonTherapy #RadiationTherapy #CancerAwareness #BreastCancer #coppafeel
-
-
IBA runs to fight breast cancer 🩷 On November 3rd, we're proud to support the Race for the Cure in Louvain-la-Neuve, standing with Think Pink and women affected by breast cancer. 👉 Join us, whether you walk or run, in this meaningful initiative: https://lnkd.in/etavE3S2 All proceeds go directly to Think Pink. 💫
💗 𝐄𝐧𝐬𝐞𝐦𝐛𝐥𝐞 𝐟𝐚𝐢𝐬𝐨𝐧𝐬 𝐫𝐞𝐜𝐮𝐥𝐞𝐫 𝐥𝐞 𝐜𝐚𝐧𝐜𝐞𝐫 𝐝𝐮 𝐬𝐞𝐢𝐧 💗 L’humain est au cœur de nos échanges voilà pourquoi, Wilink Insurance en partenariat avec Oncia Community, IBA et le Cercle du Lac ont crée leur propre « 𝑅𝑎𝑐𝑒 𝑓𝑜𝑟 𝑡ℎ𝑒 𝑐𝑢𝑟𝑒 𝐿𝑜𝑢𝑣𝑎𝑖𝑛-𝐿𝑎-𝑛𝑒𝑢𝑣𝑒» pour maquer leur soutien à l’asbl Think Pink. Nous sommes convaincus que les entreprises à travers leur influence peuvent créer un impact positif en soutenant et encourageant la prévention et l’accompagnement pour lutter contre le cancer du sein. Le 𝟑 𝐧𝐨𝐯𝐞𝐦𝐛𝐫𝐞, rejoignez-vous avec vos collaborateurs et mobilisons-nous ensemble et transformons l’effort en espoir. Rassemblons nos énergies et faisons ensemble de cette journée un moment de solidarité et d’espoir.🌸 📅 𝐑𝐞𝐣𝐨𝐢𝐠𝐧𝐞𝐳 𝐧𝐨𝐮𝐬 👉https://loom.ly/XLMew2M 💪 Une participation de 𝟏𝟗 € qui comprend: - Un T-shirt Think Pink (rose 💗 si vous avez été touché personnellement ou blanc 🤍 pour marquer votre soutien). - Votre participation à l’événement - Et surtout, 𝐯𝐨𝐭𝐫𝐞 𝐩𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐢𝐨𝐧 𝐞𝐬𝐭 𝐫𝐞𝐯𝐞𝐫𝐬𝐞́𝐞 𝐝𝐢𝐫𝐞𝐜𝐭𝐞𝐦𝐞𝐧𝐭 𝐚̀ 𝐓𝐡𝐢𝐧𝐤 𝐏𝐢𝐧𝐤. 𝐂𝐡𝐨𝐢𝐬𝐢𝐬𝐬𝐞𝐳 𝐯𝐨𝐭𝐫𝐞 𝐝𝐞́𝐟𝐢: 𝐔𝐧 𝐩𝐚𝐬, 𝐮𝐧 𝐞𝐬𝐩𝐨𝐢𝐫, 𝐮𝐧𝐞 𝐯𝐢𝐜𝐭𝐨𝐢𝐫𝐞 👟 3 km de marche – un pas symbolique pour marquer votre soutien 🏃 5 km de course – pour les plus sportifs d’entre nous 🕒 𝐋𝐮𝐧𝐝𝐢 𝟑 𝐧𝐨𝐯𝐞𝐦𝐛𝐫𝐞 𝐚̀ 𝟏𝟏𝐡𝟒𝟓 📍 𝐃𝐞́𝐩𝐚𝐫𝐭 : Wilink Insurance – 25 Boulevard Baudouin 1er, Louvain-la-Neuve 🥪 𝐀𝐫𝐫𝐢𝐯𝐞́𝐞 : Cercle du Lac – autour d’un lunch convivial Pour ce projet commun, nos engagements respectifs se rejoignent et s'unissent. Notre soutien à ThinkPink et à Oncia community vont de paire.💗
-
-
📢 Press release IBA opens the world of science and technology to secondary school girls. Yesterday's 𝐼𝑛𝑛𝑜𝑣𝑎𝑡'ℎ𝑒𝑟 event brought together female students to explore careers in STEM, fields that remain underrepresented in their academic choices. 🔗 Read the full press release here: https://lnkd.in/eQzdeQxu
-
-
Join IBA Proton Therapy User Meeting in April 2026 in Belgium! Watch the personal invitation from our founder, Yves Jongen, for IBA Proteus Users below. 🌟 👉 Register here: https://lnkd.in/eibhGXJM
𝗔𝗿𝗲 𝘆𝗼𝘂 𝗮𝗻 𝗜𝗕𝗔 𝗣𝗿𝗼𝘁𝗲𝘂𝘀 𝗨𝘀𝗲𝗿? Don’t miss the 𝗣𝗿𝗼𝘁𝗲𝘂𝘀 𝗨𝘀𝗲𝗿 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝟮𝟬𝟮𝟲 in Belgium! Get ready for an unforgettable edition gathering the IBA Proteus Community. 📅 April 24–26, 2026 📍 Dolce La Hulpe Brussels This exclusive event marks two major milestones: 🎉 25 years of patient treatments on Proteus - the first patient treated at Mass General Brigham 🎉 40 years of proton therapy innovation at IBA Join us for a unique opportunity to collaborate, share knowledge, network, and engage in strategic discussions. Watch Yves Jongen’s personal invitation below. Spots are filling fast — register now! 👉 https://lnkd.in/eibhGXJM
-
🏆 The 2025 Nobel Prize in Economics has been awarded to Joel Mokyr, Philippe Aghion and Peter Howitt for their groundbreaking work on innovation-driven growth. At IBA, this vision is our credo. We believe that technological progress, scientific curiosity, and creativity are the drivers of a better future. It’s not just a conviction, it’s our daily mission. ⭐ 🔗 Read the official announcement: https://lnkd.in/eVN6CxQX
-
-
IBA proudly supports the Oncia Community which promotes comprehensive and encompassing cancer care.
📢 Press release Oncia Community and Fundación Kālida are joining forces to expand the Kālida model across leading hospitals in Spain. The next center will open at Hospital General de Granollers, adjacent to the Radiation Oncology Center installed by Hospital Clínic of Barcelona. During the European Association of Nuclear Medicine (EANM) Congress, the partnership was celebrated with an inspiring event at the Kālida Sant Pau in Barcelona. Leading oncologists, healthcare professionals, and industry figures gathered to experience firsthand the transformative impact on cancer patients of comprehensive cancer support centers such as Kālida. The session featured heartfelt contributions from Joan Reventós (Director, Kālida Foundation), Benedetta Tagliabue (CEO, EMBT Studio and architect of Kālida Sant Pau), Olivier Legrain (President, Oncia Community & CEO, IBA), and Francoise Vamecq (Co-founder & Managing Director, Oncia Community). Notable attendees included Dra. Marta Lloret Sáez-Bravo (Head of Radiotherapy Oncology, Doctor Negrín Hospital) and Alejandro Mazal (Director of Medical Physics, Quirónsalud's Proton Therapy Centre). "At Oncia Community, we know that integrating emotional and social support with medical innovation leads to better outcomes and quality of life for cancer patients. It is encouraging to see that this approach is gaining wider recognition and that more initiatives are emerging across the oncology community," said Olivier Legrain. 🔗 Read the full press release here: https://lnkd.in/epmcpzWz
Affiliated pages
-
IBA Proton Therapy
Medical Equipment Manufacturing
Louvain-la-Neuve, Walloon Region
-
IBA Dosimetry
Medical Equipment Manufacturing
Schwarzenbruck, Bayern
-
IBA RadioPharma Solutions
Biotechnology
Louvain-la-Neuve, Brabant Wallon
-
IBA Industrial Solutions
Industrial Machinery Manufacturing
Louvain-la-Neuve, Walloon Region